Concepedia

Kenneth W. Locke

KW

Statistics

Publications

12

Citations

540

H-Index

11

Active since

1982

Affiliations

Synta Pharmaceuticals (United States)(Current)

Cubist Pharmaceuticals (United States)

Emory University

University of Massachusetts Chan Medical School

Kenneth W. Locke is an author at Synta Pharmaceuticals (United States) specializing in medicine, neuropharmacology, and pharmacology.

Publications per year

1982–2021

12

Publications

12

Synergistic Effects of a Combination of Low-Dose Basic Fibroblast Growth Factor and Citicoline After Temporary Experimental Focal Ischemia

Wolf R. Schäbitz, Fuhai Li, Katsumi Irie et al. · Stroke · 1999 · 127 citations · Full text

Medicine, Neurobiology, Pharmacology +16

The effects of prolonged treatment with citicoline in temporary experimental focal ischemia

Wolf-R. Schäbitz, Johannes Weber, Kentaro Takano et al. · Journal of the Neurological Sciences · 1996 · 109 citations

Medicine, Neurosurgery, Pharmacology +12

Synergistic Effects of Citicoline and MK-801 in Temporary Experimental Focal Ischemia in Rats

M Onal, Fuhai Li, Turgut Tatlisumak et al. · Stroke · 1997 · 88 citations

Medicine, Neurobiology, Neuroscience +17

Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkey

Kenneth W. Locke, David R. Brown, Stephen G. Holtzman · Pharmacology Biochemistry and Behavior · 1982 · 71 citations

Medicine, Animal Sciences, Pharmacology +12

Characterization of the discriminative stimulus effects of centrally administered morphine in the rat

Kenneth W. Locke, Stephen G. Holtzman · Psychopharmacology · 1985 · 36 citations

Medicine, Neuroscience, Pharmacology +12

1–5 of 12